This innovative, label-free approach offers a simple and reliable method for antibiotic susceptibility testing, with a detection limit (initial bacterial count) of 1.67×107 CFU/mL, without requiring expensive reagents or equipment.
Abstract
Antimicrobial resistance has emerged as a significant threat to global public health, necessitating accurate and rapid detection methods. To address this need, a colorimetric nanobiosensor was developed that exploits antibiotic-induced metabolic changes in bacteria, detected via the redox-dependent activity of a peroxidase-mimicking nanozyme (γ-Fe₂O₃@Prussian blue). This study aimed to differentiate resistant from susceptible E. coli strains and determine the minimum inhibitory concentration for susceptible ones using this novel principle. The experiments were conducted on two susceptible and two resistant strains of E. coli along with antibiotics, including ampicillin, cefazolin, ceftriaxone, and kanamycin. The γ-Fe2O3@PB NPs were characterized using UV-vis spectroscopy, dynamic light scattering (DLS), X-ray diffraction (XRD), transmission electron microscopy, and Fourier-transform infrared spectroscopy (FTIR). The synthesis of cubic crystalline nanoparticles with average crystallite size and hydrodynamic size of 31 nm and 219 nm, respectively, was confirmed. Upon adding H₂O₂ and the chromogenic substrate TMB to the bacterial culture supernatant, the intensity of the blue color (measured at 652 nm) in sensitive strains correlated with antibiotic concentrations. Compared to sub-MIC concentrations, a significant and sharp increase in absorbance at 652 nm was observed at the MIC, and similarly high absorbance levels were maintained at higher concentrations. By comparing the absorbance levels below and at the MIC, the MIC range can be determined. In contrast, for resistant strains, the intensity of the produced color remained nearly constant across different antibiotic concentrations. This innovative, label-free approach offers a simple and reliable method for antibiotic susceptibility testing. It achieves results in approximately 4 hours, with a detection limit (initial bacterial count) of 1.67×107 CFU/mL, without requiring expensive reagents or equipment.
These findings demonstrate that S. costus-mediated AgNPs possess favorable physicochemical properties, potent in vitro antibacterial activity against clinically important ESBL-producing pathogens, and promising preliminary cytocompatibility.
R. Hamasalih· Journal of Genetic Engineeri...· 0 citations
The biosynthesized AgNPs exhibited potent antibacterial activity against multidrug-resistant wound pathogens by disrupting bacterial membrane integrity, along with significant antioxidant and antidiabetic properties.
R. Snega, Aruchamy Mohanprasanth, Jeyasingh Immanuel Suresh et al.· Microbial Pathogenesis· 0 citations
Considering the green synthesis, biocompatible nature and outstanding anti-staphylococcal potential, the endophyte derived ZnONPs showcases their potential as a sustainable nanotechnology-based alternative to conventional antimicrobial strategies against biofilm-associated infections of S. aureus.
Amruta A. Joshi, V. M. Songire, Ravindra H. Patil· Bioscience Nanotechnology· 2 citations
The green synthesis of silver nanoparticles (PV-Ag NPs) using a pigment-producing environmental fungus, Penicillium verrucosum (PV) RPF011, as a biological reducing and stabilizing agent highlights the potential of P. verrucosum-mediated silver nanoparticles as an eco-friendly and cost-effective nanoplatform with dual...
Silver nanoparticles (AgNPs) are promising therapeutic agents against multidrug‐resistant (MDR) bacterial infections and cancer. The biogenic AgNPs were synthesized from
Argyreia speciosa (
As) leaf extract and characterized using UV–vis spectroscopy, dynamic light scattering (DLS), transmission electron microsco...
Aakash Shukla, Swapnil Tripathi, D. Parmar et al.· ChemistrySelect· 0 citations
The present work highlights the superior physicochemical and antibacterial performance of BZNAC compared with BZN, underscoring the synergistic effect of AC inclusion and validating BZNAC as a therapeutic candidate against MDR bacterial infections, warranting further preclinical and clinical testing.
Kaviya Suresh, S. Antony, M. Faiyazuddin et al.· BioNanoScience· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.